Compound for androgen receptor degradation, and pharmaceutical use thereof
US-2024383877-A1 · Nov 21, 2024 · US
US9493486B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9493486-B2 |
| Application number | US-201414569564-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 12, 2014 |
| Priority date | Jun 13, 2012 |
| Publication date | Nov 15, 2016 |
| Grant date | Nov 15, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides novel compounds having the general formula (I) wherein R 1 , R 2 , Y and W are as described herein, compositions including the compounds and methods of using the compounds.
Opening claim text (preview).
The invention claimed is: 1. A compound of formula (I) wherein R 1 is phenylalkyl substituted with R 8 , R 9 and R 10 ; R 2 is —C(O)—R 3 ; Y is —OC(O)—; W is R 3 is; and R 8 , R 9 , and R 10 are independently selected from H, alkyl, hydroxyalkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkoxy, cycloalkoxy, cycloalkoxyalkyl, cycloalkylalkoxyalkyl, alkoxy, alkoxyalkyl, haloalkoxy, haloalkoxyalkyl, alkoxyalkoxy, alkoxyalkoxyalkyl, halogen, hydroxy, cyano, alkylsulfonyl, cycloalkylsulfonyl, substituted aminosulfonyl, substituted amino and substituted aminoalkyl, wherein substituted aminosulfonyl, substituted amino and substituted aminoalkyl are substituted on the nitrogen atom with one to two substituents independently selected from hydrogen, alkyl, cycloalkyl, cycloalkylalkyl, hydroxyalkyl, alkoxyalkyl, alkylcarbonyl and cycloalkylcarbonyl; or a pharmaceutically acceptable salt thereof. 2. A The compound of claim 1 , wherein R 8 is haloalkoxy, halogen or alkylsulfonyl. 3. A The compound of claim 1 , wherein R 9 is alkyl, haloalkyl or halogen. 4. The compound of claim 1 , wherein R 10 is H. 5. The compound of claim 1 , selected from: 6. The compound of claim 5 , selected from:
Immunosuppressants, e.g. drugs for graft rejection · CPC title
Antineoplastic agents · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
Drugs for disorders of the nervous system · CPC title
of the kidneys · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.